To our knowledge, this is the first report to investigate the clinical utility of comprehensive measurement of autoimmune disease-related Abs, such as ANA, Tg Ab, TPO Ab, GAD Ab, AchR Ab, and PA-IgG, in cancer patients treated with ICIs. This evidence concerns the gene GAD1 and cancer.